|Articles|October 31, 2022
Medable Adds New Oncology Offering
Suite includes DCT applications, an eCOA oncology library, and protocol design consulting.
Advertisement
Medable announced a new oncology offering. It is an end-to-end suite that includes DCT applications such as Total Consent and Televisit, an eCOA oncology library, and protocol design consulting—with a single point of entry for patients, sites, and sponsors.
Read more about the new offering
Newsletter
Stay current in clinical research with Applied Clinical Trials, providing expert insights, regulatory updates, and practical strategies for successful clinical trial design and execution.
Advertisement
Related Content
Advertisement
Advertisement
Advertisement
.png "BioPharm International")
.png "Pharmaceutical Commerce"){kind=logo}
.png "Turbo Machinery Magazine")
.png){kind=spacer}
